MAPK3 and cancer: Our CRC cell clone studies showed that regardless of the parental cell phenotype, NMU overexpression in cells expressing NMUR2 enhances the metastatic potential of the cells by increasing their mobility and invasiveness via ERK1/2 kinase activation, as previously shown for other cancers [30, 32, 41, 42].